Page last updated: 2024-08-26

2-phenylindolone and Lung Neoplasms

2-phenylindolone has been researched along with Lung Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Z; Hu, G; Kuai, M; Li, Q; Liu, R; Lv, M; Su, Q; Tu, Z; Yang, X; Ye, S; Yu, Z; Yuan, H1

Other Studies

1 other study(ies) available for 2-phenylindolone and Lung Neoplasms

ArticleYear
Dual inhibitors of RAF-MEK-ERK and PI3K-PDK1-AKT pathways: Design, synthesis and preliminary anticancer activity studies of 3-substituted-5-(phenylamino) indolone derivatives.
    Bioorganic & medicinal chemistry, 2019, 03-15, Volume: 27, Issue:6

    Topics: A549 Cells; Amination; Aniline Compounds; Antineoplastic Agents; Apoptosis; Benzodioxoles; Cell Line, Tumor; Drug Design; Humans; Indoles; Lung Neoplasms; MAP Kinase Signaling System; Phosphatidylinositol 3-Kinase; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; raf Kinases; Signal Transduction

2019